Evaxion Biotech (EVAX) announces new positive preclinical data from its ongoing cytomegalovirus, CMV, vaccine program named EVX-V1. The data will be presented today at the 9th International Conference ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback